Vivos Therapeutics (VVOS) Other financing activities (2023 - 2026)

Vivos Therapeutics (VVOS) has 4 years of Other financing activities data on file, last reported at $567000.0 in Q1 2026.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $567000.0 in Q1 2026; TTM through Mar 2026 was $3.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $866000.0, down 88.45% from the prior year.
• Other financing activities for Q1 2026 stood at $567000.0, up from -$833000.0 in the prior quarter.
• Over the last five years, Other financing activities for VVOS reached as high as $8.0 million in Q1 2023 and fell as low as -$833000.0 in Q3 2025.
• Historically, Other financing activities has averaged $3.2 million across 4 years, with a median of $3.6 million in 2024.
• On a YoY basis, Other financing activities climbed as much as 12.5% in 2024 and fell as far as 50.74% in 2024.
• Year by year, Other financing activities stood at $4.0 million in 2023, then slipped by 12.5% to $3.5 million in 2024, then tumbled by 123.8% to -$833000.0 in 2025, then jumped by 168.07% to $567000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $567000.0 in Q1 2026, -$833000.0 in Q3 2025, and $3.5 million in Q4 2024.